Market Tracker

10/31 8:35am ET

Endocyte Inc (NASDAQ:ECYT)

6.22
Data as of Oct 30
 +0.26 / +4.36%
Today’s Change
5.31
Today|||52-Week Range
33.70
-41.76%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close5.96
Today’s open5.92
Day’s range-- - --
Volume941,965
Average volume (3 months)1,372,558
Market cap$258.4M
Dividend yield--
Data as of 10/30/2014

Growth & Valuation

Earnings growth (last year)-4.17%
Earnings growth (this year)+93.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.04%
P/E ratio23.0
Price/Sales5.93
Price/Book2.55

Competitors

 Today’s
change
Today’s
% change
GALEGalena Biopharma Inc+0.07+3.27%
HRTXHeron Therapeutics I...+0.49+5.88%
CCXIChemoCentryx Inc+0.09+1.53%
ALIMAlimera Sciences Inc-0.08-1.31%
Data as of 10/30/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$64.9M
Annual profit (last year)-$18.0M
Net profit margin-27.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
P. Ron Ellis
Chief Operating &
Financial Officer
Michael A. Sherman
Corporate headquarters
West Lafayette, Indiana

Forecasts